Join litigator Chad Shear, who was named a "2018 Winning Litigator" by The National Law Journal for his role in reversing a $2.5 billion jury verdict against client Gilead Sciences, for this comprehensive Hatch-Waxman webinar.
Chad will discuss the most common arguments made by generic drug companies when challenging branded patent portfolios. The discussion will include best practices in anticipating those arguments during prosecution, as well as how to deal with those arguments during litigation.
